Patent ID: 8536309

Claim:
A method of producing an anti-IL-22RA antibody comprising: inoculating a non-human animal with a polypeptide selected from the group consisting of: (a) a polypeptide consisting of amino acid residues 26-32 of SEQ ID NO:3; (b) a polypeptide consisting of amino acid residues 41-47 of SEQ ID NO:3; (c) a polypeptide consisting of amino acid residues 49-62 of SEQ ID NO:3; (d) a polypeptide consisting of amino acid residues 41-62 of SEQ ID NO:3; (e) a polypeptide consisting of amino acid residues 84-97 of SEQ ID NO:3; (f) a polypeptide consisting of amino acid residues 93-120 of SEQ ID NO:3; (g) a polypeptide consisting of amino acid residues 130-135 of SEQ ID NO:3; (h) a polypeptide consisting of amino acid residues 175-179 of SEQ ID NO:3; (i) a polypeptide consisting of amino acid residues 203-209 of SEQ ID NO:3; and wherein the polypeptide elicits an immune response in the animal to produce the antibody; and isolating the antibody from the animal or cells expressing the antibody; and wherein the antibody specifically binds to the IL-22RA polypeptide of SEQ ID NO:2 or SEQ ID NO:3.